Barinthus Bio (@BarinthusBio) header
Barinthus Bio (@BarinthusBio) profile picture

Barinthus Bio

@BarinthusBio

Barinthus is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates

barinthusbio.com/
Joined July 2023
  • Tweets83
  • Following99
  • Followers54
71Media
Photo by Barinthus Bio (@BarinthusBio)Photo by Barinthus Bio (@BarinthusBio)Photo by Barinthus Bio (@BarinthusBio)Photo by Barinthus Bio (@BarinthusBio)Photo by Barinthus Bio (@BarinthusBio)Photo by Barinthus Bio (@BarinthusBio)Photo by Barinthus Bio (@BarinthusBio)Photo by Barinthus Bio (@BarinthusBio)Photo by Barinthus Bio (@BarinthusBio)Photo by Barinthus Bio (@BarinthusBio)
Barinthus Bio retweeted
CEPI (@CEPIvaccines) profile picture
CEPI
@CEPIvaccines21 Dec 2023
MERS is a member of the Coronavirus family. It has caused more than 2,600 human infections in at least 27 countries since it first emerged, and it has a case-fatality rate of more than 35%. Learn more about Coronoviruses below ⬇️ endpandemics.cepi.net/the-co…
1
1
575
Barinthus Bio retweeted
Contagion (@Contagion_Live) profile picture
Contagion@Contagion_Live25 Nov 2023
Biopharmaceutical company, Barinthus Biotherapeutics, studied its investigational immunization candidate, VTP-300, together with Arbutus Biopharma’s hepatitis B (HBV) therapeutic, imdusiran. contagionlive.com/view/combi…
Combination Hepatitis B Therapy Shows Efficacy and Maintains Safety Profile | Contagion Live

Combination Hepatitis B Therapy Shows Efficacy and Maintains Safety Profile | Contagion Live

Biopharmaceutical company, Barinthus Biotherapeutics, studied its investigational immunization candidate, VTP-300, together with Arbutus Biopharma’s hepatitis B (HBV) therapeutic, imdusiran.

contagionlive.com
1
3
577
Load more